SRDX - Surmodics, Inc.
| Previous Close | 62.47 |
| Open | 62.39 |
| Bid | 0.00 x 900 |
| Ask | 73.85 x 900 |
| Day's Range | 60.33 - 62.85 |
| 52 Week Range | 25.00 - 82.35 |
| Volume | 71,124 |
| Avg. Volume | 112,146 |
| Market Cap | 834.475M |
| Beta (3Y Monthly) | 0.48 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.18 |
| Earnings Date | Nov 14, 2017 - Nov 20, 2017 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 85.00 |
- Simply Wall St.•4 days ago
What does Surmodics Inc’s (NASDAQ:SRDX) Balance Sheet Tell Us About Its Future?
Surmodics Inc (NASDAQ:SRDX), which has zero-debt on its balance sheet, can maximize capital returns by increasing debt due to its lower cost of capital. However, the trade-off is SRDX will Read More...
- Zacks•6 days ago
Express Scripts Introduces Medicare PDP Offerings for 2019
Express Scripts' (ESRX) Medicare PDP to initiate coverage from Jan 1, 2019. The plan includes Walmart along with CVS Pharmacy and the Kroger Family of Pharmacies.
- Zacks•7 days ago
Here's Why You Should Hold Ecolab Stock in Your Portfolio
Despite fluctuations in the cost of raw materials, Ecolab (ECL) to gain from strong performance in the Global Industrial segment.
- Zacks•8 days ago
AtriCure (ATRC) Looks Good: Stock Adds 6.8% in Session
AtriCure (ATRC) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
- Zacks•11 days ago
Zacks.com highlights: Lululemon Athletica, Malibu Boats, Surmodics and Baxter International
Zacks.com highlights: Lululemon Athletica, Malibu Boats, Surmodics and Baxter International
- Zacks•11 days ago
Here's Why You Should Hold Medidata Stock in Your Portfolio
Medidata's (MDSO) Clinical Cloud platform is likely to provide it a competitive edge in the MedTech space. However, cutthroat competition in the niche space is a headwind.
- Zacks•12 days ago
Buy These 4 Efficient Stocks for Stellar Returns
A company with a favorable efficiency level is expected to provide stellar returns as it is believed to be positively correlated with price performance.
- Zacks•12 days ago
Merit Medical (MMSI) to Acquire Cianna Medical, Shares Up
Merit Medical (MMSI) to leverage on Cianna Medical's SAVI and SCOUT platforms. The company plans to retain Cianna Medical's commercial and R&D teams after closure of the transaction.
- Zacks•13 days ago
Baxter Collaborates With Mayo Clinic to Open Renal Care Center
Per the agreement, Baxter (BAX) and Mayo Clinic researchers to form an outpatient clinic for kidney disease management, home dialysis and in-center dialysis services.
- Zacks•14 days ago
Surmodics Sees Hammer Chart Pattern: Time to Buy?
Surmodics has been struggling lately, but the selling pressure may be coming to an end soon.
- Zacks•19 days ago
Is Surmodics (SRDX) Outperforming Other Medical Stocks This Year?
Is (SRDX) Outperforming Other Medical Stocks This Year?
- Zacks•26 days ago
3 Top Stocks From the Booming US Medical Products Industry
The U.S. Medical Products industry is sturdy on solid focus on technological advancement.
- Zacks•27 days ago
GW Pharmaceuticals (GWPH) Catches Eye: Stock Jumps 5.9%
GW Pharmaceuticals (GWPH) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
- Zacks•28 days ago
Medical - Products Stock Outlook: Short-Term Pain Inevitable
Medical - Products Stock Outlook: Short-Term Pain Inevitable
- Zacks•last month
Here's Why You Should Invest in Surmodics (SRDX) Stock Now
Continuous focus on R&D and a raised guidance for fiscal 2018 make Surmodics (SRDX) a lucrative pick for investors.
- Zacks•last month
Baxter's Actifuse Flow Bone Graft Substitute Gets FDA Nod
The latest FDA approval for Baxter's (BAX) Actifuse Flow bone graft is likely to boost its Advanced Surgery segment.
- Zacks•last month
Zacks.com highlights: Buckle, Illumina, Surmodics and Huntington Ingalls Industries
Zacks.com highlights: Buckle, Illumina, Surmodics and Huntington Ingalls Industries
- Zacks•2 months ago
4 of the Best Efficient Stocks to Enrich Your Portfolio
A company with a favorable efficiency level is expected to provide stellar returns as it is believed to be positively correlated with price performance.
- Zacks•2 months ago
Zacks.com highlights: Illumina, Vertex Pharmaceuticals, Surmodics and McDermott International
Zacks.com highlights: Illumina, Vertex Pharmaceuticals, Surmodics and McDermott International
- Zacks•2 months ago
4 Winning Stocks With Solid Efficiency Level
A company with a favorable efficiency level is expected to provide stellar returns as it is believed to be positively correlated with price performance.
- GlobeNewswire•2 months ago
Consolidated Research: 2018 Summary Expectations for Allegiance Bancshares, TG Therapeutics, JELD-WEN Holding, Eagle Bulk Shipping, Bryn Mawr Bank, and Surmodics — Fundamental Analysis, Key Performance Indications
NEW YORK, Aug. 15, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Allegiance ...
- Zacks•2 months ago
Surmodics' (SRDX) IVD Unit Boosts Growth, R&D Focus Solid
Surmodics' (SRDX) strong focus on R&D to provide it a competitive edge in the MedTech space.
- Zacks•2 months ago
Surmodics (SRDX) Beats Q3 Earnings Estimates, Raises '18 View
Surmodics' (SRDX) third-quarter fiscal 2018 results benefit from increase in royalty and license fee revenues.
- Business Wire•2 months ago
Surmodics to Present at 7th Annual Intellisight Investor Conference
Surmodics, Inc. (SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will participate in the 7th Annual Intellisight Conference. The two-day conference, hosted by the CFA Society of Minnesota, will take place this year on Tuesday and Wednesday, August 14 and 15, in Minneapolis. Tim Arens, interim vice president of finance and chief financial officer, will present on Wednesday, August 15, at 2:30 p.m. CT (3:30 p.m. ET).
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of SRDX earnings conference call or presentation 6-Aug-18 12:30pm GMT
Q3 2018 Surmodics Inc Earnings Call
